Arrowstreet Capital
CPIX icon

Arrowstreet Capital’s Cumberland Pharmaceuticals CPIX Stock Holding History

Arrowstreet Capital’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131K Hold
20,252
– – ﹤0.01% 1869
2026
Q1 		$65.8K Buy
+20,252
New +$78K ﹤0.01% 1806
2022
Q2 		– Sell
-17,623
Closed -$50K – 1258
2022
Q1 		$50K Sell
17,623
-3,615
-17% -$12K ﹤0.01% 1147
2021
Q4 		$99K Buy
+21,238
New +$72.4K ﹤0.01% 1395
2021
Q3 		– Sell
-10,700
Closed -$30K – 1628
2021
Q2 		$30K Hold
10,700
– – ﹤0.01% 1821
2021
Q1 		$32K Buy
+10,700
New +$34.8K ﹤0.01% 2198

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital's CPIX Position: Q2 2026 in Review

Arrowstreet Capital held its Cumberland Pharmaceuticals (CPIX) position steady in Q2 2026 at 20,252 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #1869.

Arrowstreet Capital first reported a position in CPIX in Q1 2021 and has held it in 6 quarters since. 32 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

  • Arrowstreet Capital held 20,252 shares of Cumberland Pharmaceuticals worth $131K as of Q2 2026.
  • Arrowstreet Capital left its Cumberland Pharmaceuticals share count unchanged in Q2 2026.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1869 holding.
  • Arrowstreet Capital first reported a position in Cumberland Pharmaceuticals in Q1 2021 and has held it in 6 quarters since.
  • 32 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.